Financiamento
Investigador/a: Jesús San Miguel Izquierdo
12 financiamentos 3.184.081,00 €
2025
-
TERAV+
280.720,00 €
2023
2020
-
HR20-00871 GR-NET NORMAL-HIT David Lara
153.850,00 €
-
Defining the pathogenesis of multiple myeloma by integrative next-generation flow and sequencing analyses
273.158,00 €
-
HARMONY PLUS - HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES
90.000,00 €
-
Estudio Clínico de tratamiento con Andrografólido en Pacientes con Infección por CORonavirus SARS-CoV-2
240.000,00 €
2019
2018
-
Early detection and intervention: Understanding the mechanisms of transformation and hidden resistance of incurable haematological malignancies
764.890,00 €
-
CARAMBA - SLAMF7 CAR-T cells prepared by Sleeping Beauty gene-tranfer for immunotherapy of multiple myeloma - a rare hematologic disease
624.375,00 €
-
Dissecting Immune Regulation and Dysfunction within the Bone Marrow Microenvironment from Smoldering to Active Myeloma.
257.482,00 €
-
Single-cell immunophenotypic and transcriptomic profiling for minimally-invasive detection of early multiple myeloma.
143.706,00 €